A Comparative Study of Nintedanib versus Conventional Drugs in the Treatment of Inflammatory Bowel Disease-Associated Intestinal Fibrosis
{{output}}
Background: Intestinal fibrosis is a severe complication of inflammatory bowel disease (IBD) with limited effective therapeutic interventions. Nintedanib, a multi-target kinase inhibitor, exerts well-characterized antifibrotic ac... ...
